AL
Alcidion Group Limited
ALC.AX · ASX
$0.10 -4.76% (-$0.01)
1M -4.76%
Market Cap $134.4M
P/E Ratio 58.80x
Div. Yield -
ROE 2.58%
Bulios Fair Price
$0.09
10.0% downside
Current Price
$0.1
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ALC.AX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
40 /100
Fair PEG 1.54x
P/E 58.80x
P/B 1.48x
Growth
53 /100
Stable Book val. growth 0.26%
Rev. growth 8.53%
FCF growth N/A
Profitability
41 /100
Moderate Op. margin 4.94%
Gross margin 17.75%
FCF margin 12.82%
Quality
20 /100
Poor ROA 1.87%
ROIC 4.52%
Asset turnover 0.42x
Debt
93 /100
Low Int. coverage 44.77x
Debt/Equity 0.01x
Net debt/EBITDA -7.77x
Stability
44 /100
Moderate EPS volatility 122.22%
Beta 1.08x
Profitable years 2
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALC.AX
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Kate Quirke
Employees
141
Headquarters
South Yarra
Upcoming events
25 FEB
Earnings
Upcoming earnings report